Company intelligence / Profile preview
Likarda
Kansas City, Missouri, United Stateslikarda.com ↗
- Ownership
- Private
- Employees
- ~15
- Development stage
- Other
01
Overview
Likarda has demonstrated that its proprietary Core Shell Spherification® hydrogel encapsulation can extend the viability of transplanted hepatocytes in vivo without triggering immune rejection or fibrosis. This approach has shown promise in preclinical models of chronic liver disease and suggests utility for other cell therapies such as pancreatic islet transplantation. The company’s technology enables customized, durable or degradable coatings to optimize efficacy and safety of cellular therapeutics.
- Therapeutic areas
- RheumatologyGastroenterologyEndocrinology
- Modalities
- Cell therapyBiologic (large molecule)Small molecule (as delivery platform supports these)Hydrogel-based drug delivery therapyMicroencapsulation technology
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Not specifically named; open to partnering with pharma/biotech companies developing cell therapies or biologics.
Beyond the preview
Go deeper on Likarda.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Likarda.